HEALOME THERAPEUTICS Trademark

Trademark Overview


On Monday, February 27, 2023, a trademark application was filed for HEALOME THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the HEALOME THERAPEUTICS trademark a serial number of 79377648. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, June 4, 2024. This trademark is owned by Healome Therapeutics Ltd. The HEALOME THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances; pharmaceutical preparations, substances and treatment for ocular diseases and conditions; pharmaceutical preparations, substances and treatment for ocular diseases, ocular surface diseases and dry eye disease; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations, substances and treatment for dermal diseases and conditions; pharmaceutical preparations, substances and treatment for scar prevention, wound healing, medical aesthetics and orthopaedic conditions; therapeutic preparations and substances for the treatment of ocular diseases, ocular conditions, ocular surface diseases and dry eye disease; gels; therapeutic gels; gel and liquid drops, sprays, films, suspensions, and substances for the treatment of ocular diseases and conditions; gels, suspensions, and liquids for the treatment of ocular diseases and conditions; gels, suspensions, liquids and lubricants for the treatment of eye condit...

Scientific and technological services and research and design relating thereto; industrial analysis and research services; product research and development services; scientific and technological services and research services relating thereto; scientific research services for medical, biomedical and therapeutic purposes; medical and bioscience research services; biomedical research services; technical surveying and exploration services; research and development services relating to ocular diseases, treatment and conditions; research and development services relating to orthopaedics; research and development services relating to dermatology; research and development services relating to dermal applications, such as scar prevention, wound healing, medical aesthetics; research and development services relating to the treatment of diseases and conditions; research services relating to the treatment of eye diseases and conditions; therapeutic research services; advisory, consultancy and inf...
healome therapeutics

General Information


Serial Number79377648
Word MarkHEALOME THERAPEUTICS
Filing DateMonday, February 27, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, June 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of two intersecting ovals made up of small aqua, black, and navy circles with the wording "HEALOME THERAPEUTICS" located below in black. White in the mark is background and not a feature of the mark.
Goods and ServicesPharmaceutical preparations and substances; pharmaceutical preparations, substances and treatment for ocular diseases and conditions; pharmaceutical preparations, substances and treatment for ocular diseases, ocular surface diseases and dry eye disease; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations, substances and treatment for dermal diseases and conditions; pharmaceutical preparations, substances and treatment for scar prevention, wound healing, medical aesthetics and orthopaedic conditions; therapeutic preparations and substances for the treatment of ocular diseases, ocular conditions, ocular surface diseases and dry eye disease; gels; therapeutic gels; gel and liquid drops, sprays, films, suspensions, and substances for the treatment of ocular diseases and conditions; gels, suspensions, and liquids for the treatment of ocular diseases and conditions; gels, suspensions, liquids and lubricants for the treatment of eye conditions and diseases; tear film substitutes for the treatment of ocular conditions; tear film substitutes for the treatment of eye conditions and diseases; gels, suspensions, liquids and lubricants for the treatment of eye conditions, namely, glaucoma, cataracts, amblyopia, age-related macular degeneration and diabetes-related retinopathy; gels, suspensions, and liquids for medical and therapeutic use; eye drops; eye ointment; eye-washes; eye lotions for medical use; lubricating eye drops; liquid for the treatment of ocular diseases and conditions; ocular lubricants; tear film substitutes; tear substitutes for ocular diseases and conditions; tear film substitutes for ocular diseases and conditions
Indication of Colors claimedThe color(s) aqua, black and navy is/are claimed as a feature of the mark.
NOT AVAILABLETHERAPEUTICS
Goods and ServicesScientific and technological services and research and design relating thereto; industrial analysis and research services; product research and development services; scientific and technological services and research services relating thereto; scientific research services for medical, biomedical and therapeutic purposes; medical and bioscience research services; biomedical research services; technical surveying and exploration services; research and development services relating to ocular diseases, treatment and conditions; research and development services relating to orthopaedics; research and development services relating to dermatology; research and development services relating to dermal applications, such as scar prevention, wound healing, medical aesthetics; research and development services relating to the treatment of diseases and conditions; research services relating to the treatment of eye diseases and conditions; therapeutic research services; advisory, consultancy and information services relating to all the aforesaid

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 1, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHealome Therapeutics Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, August 31, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 5, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, October 25, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 25, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 25, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, October 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 28, 2023ASSIGNED TO EXAMINER
Monday, December 4, 2023NON-FINAL ACTION WRITTEN
Tuesday, December 5, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 3, 2024REFUSAL PROCESSED BY IB
Wednesday, December 13, 2023REFUSAL PROCESSED BY MPU
Wednesday, December 13, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB